That afternoon, after the stock market opened at one, Xinmin Group's stock inexplicably began to fall.
Yan Wenzheng and the others were baffled.
Their company was thriving, and they were about to secure the medical insurance slot for the new febrile disease medication. The only competition they had was Aotong Group, which had suddenly teamed up with Yang Real Estate. Yet, even so, as a foreign enterprise, Aotong's advantage wasn't as significant compared to Xinmin, the local powerhouse.
Under such circumstances, why would their own stock suddenly plummet?
"Chairman, more and more retail investors are beginning to follow suit and sell off. I've traced it back to a few large holders who were the first to short-sell Xinmin's stock in the market," someone reported.
